ライフサイエンスコーパス: Brilliant Blue

1 ellow, Amaranth, Allura Red, Indigotine, and Brilliant Blue.

2 form showed greater selectivity in detecting brilliant blue.

3 injection analysis was employed to determine brilliant blue.

4 on assays, we found that Alexa Fluor 647 and Brilliant Blue 700 (BB700) dyes had the greatest labelin

5 ximately 50 pmol per zone for both Coomassie Brilliant Blue and Amaranth dyes; these values were 0.4

6 end-point, cells were stained with Coomassie brilliant blue and area was determined using image analy

7 After staining with Coomassie brilliant blue and destaining, the gels were analyzed wi

8 8 kDa that was weakly stained with Coomassie Brilliant Blue and strongly stained with silver.

9 uantitation of tartrazine in the presence of brilliant blue and sunset yellow FCF as possible interfe

10 Coomassie brilliant blue binding was used to indicate conformation

11 ing ARPE-19 for 10 minutes with trypan blue, brilliant blue, bromophenol blue, fast green, light gree

12 Examples include brilliant blue, carmoisine, sunset yellow, allura red, a

13 ate (SDS) upon the response of the Coomassie Brilliant Blue (CBB) and Pyrogallol Red-molybdate (PRM)

14 Gel destaining following Coomassie Brilliant Blue (CBB) staining involves the use of toxic

15 teins were electrophoresed and the Coomassie Brilliant Blue (CBB)-positive bands were analyzed to ide

16 nonfluorescing chromophore label, Coomassie Brilliant Blue (CBB).

17 ity of commonly used staining dye 'coomassie brilliant blue' (CBB) towards GMP.

18 ity of commonly used staining dye 'coomassie brilliant blue' (CBB) towards GMP.

19 ent exhibited a linear relationship with the brilliant blue concentration within the range of 0.01-1.

20 The Coomassie brilliant blue dye-binding method for protein assay has

21 ), Amaranth (E123), Sunset Yellow (E110) and Brilliant Blue (E133) were extracted from soft drinks us

22 Patent Blue V (E131), Indigo Carmine (E132), Brilliant Blue (E133), Green S (E142), Fast Green (E143)

23 loped for seperation and preconcentration of Brilliant Blue FCF (BB) by the prepared MNG.

24 exin 1 channels using carbenoxolone (CBX) or Brilliant Blue FCF (BB-FCF) (1-100 mum, intravesically),

25 have been developed for preconcentration of Brilliant Blue FCF (E133) from some food products by the

26 luminescence as the reporter system, the dye Brilliant Blue FCF as the signal-masking reagent, and bu

27 per oxide nanoparticles for the detection of brilliant blue FCF from various soft beverages was devel

28 , the structurally related food-coloring dye Brilliant Blue FCF had very little effect at concentrati

29 istration of the pannexin channel antagonist Brilliant Blue FCF increased bladder capacity, whereas i

30 to real samples for the preconcentration of Brilliant Blue FCF.

31 is blocked by oxidized ATP (100 microm) and Brilliant Blue G (1 microm).

32 or antagonists oxidized ATP (100 microm) and Brilliant Blue G (2 microm).

33 king agents BAY 11-7082 (30 mg/kg, i.p.) and Brilliant Blue G (BBG) (45.5 mg/kg, i.p.) in a mouse mod

34 rgery using xenon endolight illumination and Brilliant blue G (BBG) dye.

35 Brilliant blue G (BBG), best known as an antagonist of P

36 systemically administered P2X7R antagonist, Brilliant blue G (BBG), in a weight-drop model of thorac

37 n extracellular Ca(2+), and was prevented by brilliant blue G (BBG).

38 riodate oxidised ATP (OxATP: 100 microM) and brilliant blue G (BBG: 1 microM), but not by suramin (10

39 led area, but were matched to the area where brilliant blue G accidentally entered the subretinal spa

40 and microperimetry indicate that subretinal brilliant blue G might cause focal macular damage with a

41 nal changes in his right eye associated with brilliant blue G migration into the subretinal space dur

42 inhibited by the P2X(7) receptor inhibitors Brilliant Blue G or A 438079.

43 hosphate-6-azophenyl-2',4'-disulphonic acid, Brilliant Blue G or periodate oxidized ATP dialdehyde to

44 Animal data demonstrate Brilliant Blue G to be an effective capsular stain with

45 In mdx/mdx mice treated with Brilliant Blue G, a P2X7 blocker, these blood lymphocyte

46 Brilliant blue G, a selective P2X(7) antagonist, suppres

47 ) permeability to Na+, and (e) inhibition by Brilliant Blue G, Cu2+, and pyridoxal phosphate-6-azophe

48 For the larger antagonists, brilliant blue G, KN-62, and calmidazolium, our data imp

49 he P2X7R-selective antagonists ZINC58368839, brilliant blue G, KN-62, and calmidazolium.

50 In all eyes stained with brilliant blue G, the preoperative diagnosis of large IL

51 -5-phosphate-6-azo-2',4'-disulfonic acid and Brilliant Blue G, with half-maximal inhibition at 3, 0.2

52 Bradford reagent, comprised of the Coomassie Brilliant Blue G-250 dye, methanol, and phosphoric acid,

53 nnel blockers, but not by the P2X(7) blocker Brilliant blue G.

54 ABA(A)) receptor agonists were unaffected by brilliant blue G.

55 P and BzATP and inhibited by zinc, Coomassie Brilliant Blue-G, and KN-62, demonstrating activation of

56 ed overlapping sensitivity to the inhibitors Brilliant Blue, gadolinium, and carbenoxolone.

57 ing species of Begonia(5), notable for their brilliant blue iridescence, have a photonic crystal stru

58 used as adsorbent for removing toxic remazol brilliant blue R (RBBR).

59 Addition of contrast agents (trypan blue or brilliant blue R) improve the signal-to-noise ratio by q

60 Coomassie brilliant blue R-250 (CBB) is a popular and widely used

61 w/v) solution of the protein stain Coomassie Brilliant Blue R-250 for 16 to 24 h and then destained.

62 120, reactive black-5, brilliant yellow, and brilliant blue-R.

63 parable to that of the traditional Coomassie Brilliant Blue staining procedure.

64 was utilized for sensitive detection of the brilliant blue synthetic dye, achieving a limit of detec

65 hermore, the signal towards the oxidation of brilliant blue was examined using the differential pulse

66 tents of other colorants i.e. Tartrazine and Brilliant Blue were within 4.74-140.284 mg/kg.